D'Light Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 30.00 K
as on 04-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.00 M
as on 04-12-2024
- Revenue 115.60%
(FY 2022)
- Profit 645.37%
(FY 2022)
- Ebitda 667.65%
(FY 2022)
- Net Worth 107.87%
(FY 2022)
- Total Assets 116.49%
(FY 2022)
About D'Light Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 30.00 K .
The company currently has active open charges totaling ₹4.00 M.
Geeta Pal and Rajesh Pal serve as directors at the Company.
- CIN/LLPIN
U51909MH2020PTC341101
- Company No.
341101
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Social Media-
What products or services does D'light Lifescience Private Limited offer?
D'Light Lifescience Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Mineral Supplement, Sexual Wellness Products, Fertility Enhancer, Vitamin Tablets & Capsules.
Who are the key members and board of directors at D'Light Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Pal  | Director | 28-Jun-2020 | Current |
| Rajesh Pal | Director | 28-Jun-2020 | Current |
Financial Performance of D'Light Lifescience.
D'Light Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 115.6% increase. The company also saw a substantial improvement in profitability, with a 645.37% increase in profit. The company's net worth Soared by an impressive increase of 107.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D'Light Lifescience?
In 2022, D'Light Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dlight Medical Devices Private LimitedActive 1 year 5 monthsGeeta Pal and Rajesh Pal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Oct 2022 | ₹4.00 M | Open |
How Many Employees Work at D'Light Lifescience?
D'Light Lifescience has a workforce of 10 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D'Light Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D'Light Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
